Low vs standard dose valganciclovir
CMV infection · solid organ transplant recipients
Low showed no clear difference in CMV infection compared with standard dose valganciclovir (low certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 0.37 [0.11, 1.22]2 studies · 256 participantsLow